Skip to main content

Table 3 Association between clinicopathologic features and K-ras, c-mos, K-ras-c-mos, K-ras/c-mos, MVD, and VEGF

From: Relationship of the K-ras/c-mos Expression Patterns With Angiogenesis in Non-Small Cell Lung Carcinomas

Status

Histology

p

LN

p

Stage

p

MVD (microvessels/mm2)

0.850a

0.894a

0.264b

VEGF

0.278c

0.315c

0.742c

K-ras

0.212d

0.873d

0.980d

c-mos

0.752d

0.532d

0.085d

K-ras-c-mose

0.562d

0.571d

0.265d

K-ras/c-mosf

0.855d

0.882d

0.339d

  1. at-test analysis.
  2. bANOVA.
  3. cKruskal-Wallis analysis.
  4. dPearson’s chi-square analysis.
  5. eCategorization based on the complete absence or presence of at least one aberration in K-ras or c-mos (see Results section 4).
  6. fCategorization into groups according to K-ras and c-mos status (see Results section 4).